Holders over time
- PM
- CVS
| Quarter | PM | CVS |
|---|---|---|
| Q3 2020 | 25 holders, $19.7bn | 29 holders, $8.9bn |
| Q4 2020 | 25 holders, $21.5bn | 22 holders, $9.8bn |
| Q1 2021 | 27 holders, $22.1bn | 28 holders, $10.3bn |
| Q2 2021 | 20 holders, $23.2bn | 24 holders, $11.8bn |
| Q3 2021 | 25 holders, $22.8bn | 28 holders, $11.9bn |
| Q4 2021 | 26 holders, $22.3bn | 28 holders, $14.7bn |
| Q1 2022 | 29 holders, $23.2bn | 25 holders, $14.4bn |
| Q2 2022 | 28 holders, $25.8bn | 30 holders, $13.5bn |
| Q3 2022 | 33 holders, $22.2bn | 28 holders, $13.9bn |
| Q4 2022 | 26 holders, $27.0bn | 30 holders, $12.6bn |
| Q1 2023 | 36 holders, $27.6bn | 36 holders, $9.6bn |
| Q2 2023 | 29 holders, $28.9bn | 33 holders, $9.8bn |
| Q3 2023 | 32 holders, $28.5bn | 33 holders, $11.7bn |
| Q4 2023 | 34 holders, $28.8bn | 32 holders, $14.2bn |
| Q1 2024 | 36 holders, $28.4bn | 21 holders, $14.3bn |
| Q2 2024 | 31 holders, $31.4bn | 24 holders, $14.2bn |
| Q3 2024 | 39 holders, $38.2bn | 31 holders, $14.2bn |
| Q4 2024 | 40 holders, $36.6bn | 32 holders, $11.0bn |
| Q1 2025 | 44 holders, $49.1bn | 29 holders, $19.1bn |
| Q2 2025 | 44 holders, $54.3bn | 31 holders, $19.6bn |
| Q3 2025 | 36 holders, $49.3bn | 28 holders, $21.9bn |
| Q4 2025 | 26 holders, $50.5bn | 29 holders, $22.8bn |
| Q1 2026 | 25 holders, $57.3bn | 32 holders, $21.1bn |
| Q2 2026 | 27 holders, $63.8bn | 31 holders, $30.8bn |
Philip Morris Intl Inc
- Holders
- 39
- Reported value
- $38.2bn
- Buyers
- 22
- Sellers
- 15
Breadth +7 among 94 comparable managers.
CVS Health Corp
- Holders
- 31
- Reported value
- $14.2bn
- Buyers
- 23
- Sellers
- 10
Breadth +13 among 94 comparable managers.
Who holds both, Q3 2024
Both (19)
AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, D. E. Shaw & Co., Dodge & Cox, Fidelity (FMR LLC), Harris Associates LP, Invesco Ltd, Janus Henderson Group Ltd, Marshall Wace LLP, Millennium Management LLC, Quantbot Technologies LP, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC
Only PM (20)
Acadian Asset Management LLC, Artisan Partners LP, Baillie Gifford & Co, Brevan Howard Capital Management LP, Citadel Advisors LLC, D1 Capital Partners LP, Discovery Capital Management LLC, ExodusPoint Capital Management LP, First Eagle Investment Management LLC, Holocene Advisors LP, Lone Pine Capital LLC, Man Group PLC, Markel Group Inc, Maverick Capital Ltd, MFS Investment Management, Neuberger Berman Group LLC, Verition Fund Management LLC, Viking Global Investors LP, Wellington Management Group LLP, Winton Group Ltd
Only CVS (12)
Balyasny Asset Management LLC, Caxton Associates LLP, Eisler Capital Management Ltd, GAMCO Investors Inc, Glenview Capital Management LLC, Point72 Asset Management LP, Renaissance Technologies LLC, Sachem Head Capital Management LP, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Third Point LLC, Tudor Investment Corp
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.